Pulmonary Disease in a Psychiatric Inpatient Population

Not Applicable

Completed

• Conditions: Chronic Obstructive Airway Disease
• Interventions: Procedure: Spirometry with reversibility test

• Registration Number: NCT01823627
• Lead Sponsor: Psykiatrien Syd

Brief Summary

Purpose: Patients with mental health disorders have a reduced life expectancy, compared to the general population. The shorter life expectancy is caused by natural and unnatural death. In general, patients with a mental disorder tend to have a more unhealthy lifestyle, than the general population, characterized by e.g. lack of exercise and smoking.

Hypothesis

Chronic obstructive pulmonary disease (COPD) is underdiagnosed in psychiatric inpatients There is a higher prevalence of COPD in psychiatric inpatients compared to the general population Screening of patients with one respiratory symptom and a smoking history, has the same sensitivity regarding to diagnosis of COPD, as screening all patients with a smoking history

Method:

80 psychiatric inpatients will undergo spirometry with reversibility test and COPD Assessment Test (CATest). Furthermore, patient history regarding respiratory symptoms and smoking will be taken into account.

Detailed Description

Not available

Study Timeline

• Study Start: 2013-03
• Study First Submitted: 2013-03-26
• Study First Submitted QC: 2013-04-02
• Study First Posted: 2013-04-04
• Primary Completion: 2013-06
• Study Completion: 2013-07
• Status Verified: 2018-05
• Last Update Submitted: 2018-05-22
• Last Update Posted: 2018-05-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 46

Inclusion Criteria

• Inpatients in Psykiatrien Syd, Region Zealand, ward S1,S2,S3,S4,S5,S6
• Admission time over 48 hours

Exclusion Criteria

• Patients who is not able to perform spirometry due to their psychiatric condition

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Spirometry with reversibility test	Spirometry with reversibility test	Spirometry with reversibility test

Primary Outcome Measures

Name	Time	Method
Tiffeneau index	at enrollment	- FEV1/FVC ratio

Secondary Outcome Measures

Name	Time	Method
forced vital capacity	at enrollment	FVC L/s
Forced expiratory volume in 1 second	at enrollment	FEV1 L

Trial Locations

Locations (1)

Psyciatrien Syd, Region Zealand; 🇩🇰 Vordingborg, Denmark